RadNet (RDNT) Tops Q3 EPS by 4c
RadNet (NASDAQ: RDNT) reported Q3 EPS of $0.10, $0.04 better than the analyst estimate of $0.06. Revenue for the quarter came in at $175.2 million versus the consensus estimate of $177.85 million.
Aggregate and same-center procedural volumes increased 9.2% and 6.3%, respectively, from the third quarter of 2013; volumes continue to be enhanced by services provided to enrollees in state and privately managed health insurance exchanges
2014 Guidance Update
RadNet updates the previously announced 2014 fiscal year guidance ranges as follows:
| Revised | ||
| Guidance | ||
| Original | After 3rd | |
| 2014 Guidance | Quarter 2014 | |
| Revenue (a) | $700 - $730mm | $730 - $745mm |
| Adjusted EBITDA(1) | $110 - $120mm | $123 - $128mm |
| Capital Expenditures (b) | $40 - $45mm | $50 - $52mm |
| Cash Interest Expense | $38 - $42mm | $40 - 42mm |
| Free Cash Flow Generation (c)(2) | $30 - $40mm | $30 - $36mm |
| (a) Service Fee Revenue, net of contractual allowances plus Revenue under capitation arrangements. | ||
| (b) Net of proceeds from the sale of equipment, imaging centers and joint venture interests. | ||
| (c) Defined by the Company as Adjusted EBITDA(1) less total capital expenditures and cash paid for interest. | ||
For earnings history and earnings-related data on RadNet (RDNT) click here.